Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Skin Diseases | 2 | 2020 | 366 | 1.000 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2020 | 156 | 0.650 |
Why?
|
| Imipramine | 1 | 2017 | 32 | 0.590 |
Why?
|
| Hyperpigmentation | 1 | 2017 | 34 | 0.590 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2017 | 38 | 0.590 |
Why?
|
| Ear Diseases | 1 | 2016 | 23 | 0.550 |
Why?
|
| Foreign-Body Reaction | 1 | 2016 | 31 | 0.550 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 2020 | 285 | 0.550 |
Why?
|
| Keratin-1 | 1 | 2016 | 2 | 0.550 |
Why?
|
| Hyperkeratosis, Epidermolytic | 1 | 2016 | 7 | 0.540 |
Why?
|
| Keratoderma, Palmoplantar | 1 | 2016 | 9 | 0.540 |
Why?
|
| Purpura Fulminans | 1 | 2015 | 6 | 0.530 |
Why?
|
| Angiokeratoma | 1 | 2015 | 1 | 0.520 |
Why?
|
| Pseudolymphoma | 1 | 2015 | 22 | 0.510 |
Why?
|
| Nail Diseases | 1 | 2015 | 39 | 0.500 |
Why?
|
| Pemphigus | 1 | 2014 | 9 | 0.490 |
Why?
|
| Photosensitivity Disorders | 1 | 2014 | 22 | 0.480 |
Why?
|
| West Nile virus | 1 | 2015 | 132 | 0.460 |
Why?
|
| Immunoglobulin A | 1 | 2014 | 271 | 0.450 |
Why?
|
| Gout | 1 | 2016 | 146 | 0.450 |
Why?
|
| West Nile Fever | 1 | 2015 | 157 | 0.440 |
Why?
|
| Depressive Disorder | 1 | 2017 | 565 | 0.440 |
Why?
|
| Drug Eruptions | 1 | 2014 | 271 | 0.400 |
Why?
|
| Sporotrichosis | 1 | 2011 | 3 | 0.390 |
Why?
|
| Diagnostic Errors | 1 | 2016 | 518 | 0.390 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 1129 | 0.360 |
Why?
|
| Fluorouracil | 1 | 2014 | 1990 | 0.340 |
Why?
|
| Carcinoma, Basal Cell | 3 | 2020 | 290 | 0.330 |
Why?
|
| Deoxycytidine | 1 | 2014 | 1389 | 0.320 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2014 | 1347 | 0.300 |
Why?
|
| Skin Neoplasms | 4 | 2019 | 4895 | 0.280 |
Why?
|
| Face | 3 | 2019 | 252 | 0.240 |
Why?
|
| Dermatology | 1 | 2024 | 72 | 0.220 |
Why?
|
| Delphi Technique | 1 | 2024 | 275 | 0.210 |
Why?
|
| Diagnosis, Differential | 3 | 2020 | 4831 | 0.190 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2020 | 70 | 0.180 |
Why?
|
| Bendamustine Hydrochloride | 1 | 2020 | 123 | 0.170 |
Why?
|
| Mutation | 2 | 2020 | 15912 | 0.170 |
Why?
|
| Consensus | 1 | 2024 | 1106 | 0.170 |
Why?
|
| Plasma Cells | 1 | 2020 | 197 | 0.170 |
Why?
|
| Sweat Gland Neoplasms | 1 | 2020 | 72 | 0.170 |
Why?
|
| Immunoglobulin M | 1 | 2020 | 359 | 0.160 |
Why?
|
| Curriculum | 1 | 2024 | 919 | 0.150 |
Why?
|
| Eyelid Neoplasms | 1 | 2020 | 193 | 0.150 |
Why?
|
| Cataract | 1 | 2020 | 236 | 0.140 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2020 | 331 | 0.140 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2020 | 605 | 0.140 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2020 | 442 | 0.130 |
Why?
|
| Rare Diseases | 2 | 2020 | 360 | 0.130 |
Why?
|
| Ear Neoplasms | 1 | 2016 | 64 | 0.130 |
Why?
|
| Gangrene | 1 | 2015 | 27 | 0.130 |
Why?
|
| Biopsy, Needle | 2 | 2020 | 1379 | 0.130 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2015 | 99 | 0.120 |
Why?
|
| Lymphocytes | 1 | 2020 | 1275 | 0.120 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2014 | 19 | 0.120 |
Why?
|
| Rituximab | 1 | 2020 | 1594 | 0.120 |
Why?
|
| Neck | 1 | 2017 | 395 | 0.120 |
Why?
|
| Fingers | 1 | 2015 | 130 | 0.120 |
Why?
|
| Humans | 14 | 2024 | 270740 | 0.110 |
Why?
|
| Capecitabine | 1 | 2014 | 390 | 0.110 |
Why?
|
| Internship and Residency | 1 | 2024 | 1452 | 0.110 |
Why?
|
| Aged | 7 | 2020 | 73333 | 0.110 |
Why?
|
| Bone Marrow | 1 | 2020 | 2441 | 0.100 |
Why?
|
| Female | 9 | 2020 | 148940 | 0.100 |
Why?
|
| Sporothrix | 1 | 2011 | 2 | 0.100 |
Why?
|
| Cats | 1 | 2011 | 169 | 0.090 |
Why?
|
| Itraconazole | 1 | 2011 | 82 | 0.090 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2020 | 1335 | 0.090 |
Why?
|
| Immunohistochemistry | 3 | 2020 | 7655 | 0.090 |
Why?
|
| Nose Neoplasms | 2 | 2011 | 242 | 0.090 |
Why?
|
| Cell Differentiation | 1 | 2020 | 4116 | 0.080 |
Why?
|
| Aminoquinolines | 1 | 2008 | 52 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2016 | 5593 | 0.080 |
Why?
|
| Mohs Surgery | 1 | 2008 | 103 | 0.070 |
Why?
|
| Antifungal Agents | 1 | 2011 | 880 | 0.060 |
Why?
|
| Cultural Diversity | 1 | 2024 | 80 | 0.060 |
Why?
|
| Male | 6 | 2020 | 128315 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2016 | 8699 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2020 | 33737 | 0.050 |
Why?
|
| Child | 2 | 2015 | 30559 | 0.050 |
Why?
|
| Adult | 2 | 2016 | 82040 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 16689 | 0.040 |
Why?
|
| Cataract Extraction | 1 | 2020 | 212 | 0.040 |
Why?
|
| Prognosis | 1 | 2015 | 22505 | 0.040 |
Why?
|
| Head and Neck Neoplasms | 1 | 2011 | 4147 | 0.030 |
Why?
|
| Middle Aged | 3 | 2019 | 90352 | 0.030 |
Why?
|
| Melanoma | 1 | 2011 | 5595 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 5923 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 14617 | 0.020 |
Why?
|
| S100 Proteins | 1 | 2011 | 186 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2019 | 4048 | 0.020 |
Why?
|
| Keratins | 1 | 2011 | 340 | 0.020 |
Why?
|
| Ointments | 1 | 2008 | 23 | 0.020 |
Why?
|
| Administration, Topical | 1 | 2008 | 258 | 0.020 |
Why?
|
| Animals | 1 | 2011 | 61956 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 15218 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2008 | 2580 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2011 | 30998 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 7238 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 9039 | 0.010 |
Why?
|